Corporeal Weight Gain and Metabolic Syndrome in Living Kidney Donors After Nephrectomy

Transplantation Proceedings

Volumn 39, Issue 2, 2007, Pages 403-406

  Ferreira Filho, S R ^a   da Silva Passos, L ^a   Ribeiro, M B ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; EVALUATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DONOR; KIDNEY FUNCTION; LIVING DONOR; MALE; METABOLIC SYNDROME X; NEPHRECTOMY; NEPHRON; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; WAIST CIRCUMFERENCE; WEIGHT GAIN;

FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; LIVING DONORS; METABOLIC SYNDROME X; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RISK FACTORS; WEIGHT GAIN;

EID: 33847711812     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.01.028     Document Type: Article

References (16)

1. Najarian J.S. Living donor kidney transplants: personal reflections. Transplant Proc 379 (2005) 3592
2. Praga M., Hernandez E., Herrero J.C., et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58 (2000) 2111
3. Gonzalez E., Gutierrez E., Morales E., et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int 681 (2005) 263
4. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167
5. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134
6. National Cholesterol Education Program (NCEP): Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 10625 (2002) 3143
7. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
8. National Institutes of Health. Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Executive summary. Available at: www.nhlbi.nih.gov Accessed on 11/13/2006
9. Chobanian AV, Bakris GL, Black HR, et al: Hypertension 42:1206, 2003
10. Ciszek M., Paczek L., and Rowinski W. Clinical outcome of living kidney donation. Transplant Proc 35 (2003) 1179
11. Najarian J.S., Chavers B.M., McHugh L.E., et al. 20 years or more of follow-up of living kidney donors. Lancet 340 (1992) 807
12. Saran R., Marshall S.M., Madsen R., et al. Long-term follow-up of kidney donors: a longitudinal study. Nephrol Dial Transplant 12 (1997) 1615
13. Regazzoni B.M., Genton N., Pelet J., et al. Long-term followup of renal functional reserve capacity after unilateral nephrectomy in childhood. J Urol 160 (1998) 844
14. Rizvi S.A., Naqvi S.A., Jawad F., et al. Living kidney donor follow-up in a dedicated clinic. Transplantation 79 (2005) 1247
15. Ramcharan T., and Matas A.J. Long-Term (20-37 years) Follow-up of living kidney donors. Am J Transpl 2 (2002) 959
16. Whelton P.K., Pemeger T.V., He J., et al. The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic. J Hum Hypertens 10 (1996) 683